"Cardiac glycosides"-quo vaditis?-past, present, and future?
Atrial fibrillation
Cancer
Cardiac glycosides
Digitalis glycosides
Digitoxin
Digoxin
Heart failure
Metabolism
NKA inhibitors
Na+/K+-ATPase
Toxicity
Journal
Naunyn-Schmiedeberg's archives of pharmacology
ISSN: 1432-1912
Titre abrégé: Naunyn Schmiedebergs Arch Pharmacol
Pays: Germany
ID NLM: 0326264
Informations de publication
Date de publication:
15 Jul 2024
15 Jul 2024
Historique:
received:
22
05
2024
accepted:
03
07
2024
medline:
15
7
2024
pubmed:
15
7
2024
entrez:
15
7
2024
Statut:
aheadofprint
Résumé
Up to date, digitalis glycosides, also known as "cardiac glycosides", are inhibitors of the Na
Identifiants
pubmed: 39007928
doi: 10.1007/s00210-024-03285-3
pii: 10.1007/s00210-024-03285-3
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Bundesministerium für Bildung und Forschung
ID : 03INT703AB
Organisme : Deutsche Forschungsgemeinschaft
ID : 453989101
Informations de copyright
© 2024. The Author(s).
Références
Ahmed A, Rich MW, Love TE, Lloyd-Jones DM, Aban IB, Colucci WS, Adams KF, Gheorghiade M (2006) Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 27:178–186. https://doi.org/10.1093/eurheartj/ehi687
doi: 10.1093/eurheartj/ehi687
pubmed: 16339157
Ainembabazi D, Zhang Y, Turchi JJ (2023) The mechanistic role of cardiac glycosides in DNA damage response and repair signaling. Cell Mol Life Sci 80(250):1–13. https://doi.org/10.1007/s00018-023-04910-9
doi: 10.1007/s00018-023-04910-9
Altamirano J, Li Y, DeSantiago J, Piacentino V 3rd, Houser SR, Bers DM (2006) The inotropic effect of cardioactive glycosides in ventricular myocytes requires Na+-Ca2+ exchanger function. J Physiol 575(3):845–854. https://doi.org/10.1113/jphysiol.2006.111252
doi: 10.1113/jphysiol.2006.111252
pubmed: 16825310
pmcid: 1995692
Amarelle L, Katzen J, Shigemura M, Welch LC, Cajigas H, Peteranderl C, Celli D, Herold S, Lecuona E, Sznajder JI (2019) Cardiac glycosides decrease influenza virus replication by inhibiting cell protein translational machinery. Am J Physiol Lung Cell Mol Physiol 316:L1094–L1106. https://doi.org/10.1152/ajplung.00173.2018
doi: 10.1152/ajplung.00173.2018
pubmed: 30892074
pmcid: 6620673
Ambrosy AP, Butler J, Ahmed A, Vaduganathan M, van Veldhuisen DJ, Colucci WS, Gheorghiade M (2014) The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions. J Am Coll Cardiol 63(18):1823–1832. https://doi.org/10.1016/j.jacc.2014.01.051
doi: 10.1016/j.jacc.2014.01.051
pubmed: 24613328
Askari A (2019) The sodium pump and digitalis drugs: dogmas and fallacies. Pharmacol Res Perspect 7(4):1–6. https://doi.org/10.1002/prp2.505
doi: 10.1002/prp2.505
Banaag AL, Pollard HB, Koehlmoos TP (2023) Digoxin and standard-of-care therapy for heart failure patients with COVID-19: analysis of data from the US Military Health System (MHS) data repository. Drugs - Real World Outcomes 10:299–307. https://doi.org/10.1007/s40801-023-00360-8
doi: 10.1007/s40801-023-00360-8
pubmed: 36933173
pmcid: 10024520
Bavendiek U, Berliner D, Dávila LA, Schwab J, Maier L, Philipp SA, Rieth A, Westenfeld R, Piorkowski C, Weber K, Hänselmann A, Oldhafer M, Schallhorn S, von der Leyen H, Schröder C, Veltmann C, Störk S, Böhm M, Koch A, Bauersachs J (2019) Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study. Eur J Heart Fail 21:676–684. https://doi.org/10.1002/ejhf.1452
doi: 10.1002/ejhf.1452
pubmed: 30892806
Bavendiek U, Großhennig A, Schwab J, Berliner D, Liu X, Maier L, Gaspar T, Rieth A, Philipp S, Hambrecht R, Westenfeld R, Münzel T, Winkler S, Hülsmann M, Westermann D, Zdravkovic M, Lichtinghagen R, von der Leyen H, Zimmermann S, … Bauersachs J (2023) Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial. Clin Res Cardiol 112:1096–1107. https://doi.org/10.1007/s00392-023-02199-z
Bejček J, Jurášek M, Spiwok V, Rimpelová S (2021) Quo vadis cardiac glycoside research? Toxins 13(344). https://doi.org/10.3390/toxins13050344
Belz GG, Breithaupt-Grögler K, Osowski U (2001) Treatment of congestive heart failure - current status of use of digitoxin. Eur J Clin Invest 31:10–17. https://doi.org/10.1111/j.1365-2362.2001.00012.x
doi: 10.1111/j.1365-2362.2001.00012.x
pubmed: 11525233
Blaustein MP, Hamlyn JM (2024) Sensational site: the sodium pump ouabain-binding site and its ligands. Am J Physiol Cell Physiol 326(4):C1120–C1177. https://doi.org/10.1152/ajpcell.00273.2023
doi: 10.1152/ajpcell.00273.2023
pubmed: 38223926
pmcid: 11193536
Blaustein MP, Robinson SW, Gottlieb SS, Balke CW, Hamlyn JM (2003) Sex, digitalis, and the sodium pump. Mol Interv 3(2):68–78. https://doi.org/10.1124/mi.3.2.68
doi: 10.1124/mi.3.2.68
pubmed: 14993426
Bøhmer T, Røseth A (1998) Prolonged digitoxin half-life in very elderly patients. Age Ageing 27:222–224. https://doi.org/10.1093/ageing/27.2.222
doi: 10.1093/ageing/27.2.222
pubmed: 16296683
Botelho AFM, Pierezan F, Soto-Blanco B, Melo MM (2019) A review of cardiac glycosides: structure, toxicokinetics, clinical signs, diagnosis and antineoplastic potential. Toxicon 158:63–68. https://doi.org/10.1016/j.toxicon.2018.11.429
doi: 10.1016/j.toxicon.2018.11.429
pubmed: 30529380
Brand T, Lukannek AK, Jahns V, Jahns R, Lorenz K (2024) From “contraindicated” to “first line” – current mechanistic insights beyond canonical β-receptor signaling. Curr Opin Pharmacol 76:102458. https://doi.org/10.1016/j.coph.2024.102458
doi: 10.1016/j.coph.2024.102458
pubmed: 38636195
Braunwald E (1985) Effects of digitalis on the normal and the failing heart. J Am Coll Cardiol 5(5):51A-59A. https://doi.org/10.1016/S0735-1097(85)80463-0
doi: 10.1016/S0735-1097(85)80463-0
pubmed: 3886752
Brown BT, Stafford A, Wright SE (1962) Chemical structure and pharmacological activity of some derivatives of digitoxigenin and digoxigenin. Br J Pharmacol Chemother 18:311–324. https://doi.org/10.1111/j.1476-5381.1962.tb01411.x
doi: 10.1111/j.1476-5381.1962.tb01411.x
pubmed: 13873586
pmcid: 1482116
Bunting KV, Stanbury M, Tica O, Kotecha D (2021) Transforming clinical research by involving and empowering patients - the RATE-AF randomized trial. Eur Heart J 42(25):2411–2414. https://doi.org/10.1093/eurheartj/ehab098
doi: 10.1093/eurheartj/ehab098
pubmed: 33655299
pmcid: 8248994
Buterbaugh GG, Spratt JL (1970) Observations on the possible role of central mechanisms in acute digitoxigenin toxicity. Toxicol Appl Pharmacol 17(2):387–399. https://doi.org/10.1016/0041-008X(70)90196-1
doi: 10.1016/0041-008X(70)90196-1
pubmed: 4394305
Bylda C, Thiele R, Kobold U, Bujotzek A, Volmer DA (2015) Rapid quantification of digitoxin and its metabolites using differential ion mobility spectrometry-tandem mass spectrometry. Anal Chem 87:2121–2128. https://doi.org/10.1021/ac503187z
doi: 10.1021/ac503187z
pubmed: 25588102
Caohuy H, Eidelman O, Chen T, Liu S, Yang Q, Bera A, Walton NI, Wang TT, Pollard HB (2021) Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells. Nat Sci Rep 11:1–14. https://doi.org/10.1038/s41598-021-01690-9
doi: 10.1038/s41598-021-01690-9
Castagno D, Petrie MC, Claggett B, McMurray J (2012) Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure. Eur Heart J 33:1137–1141. https://doi.org/10.1093/eurheartj/ehs004
doi: 10.1093/eurheartj/ehs004
pubmed: 22408030
Clausen MV, Hilbers F, Poulsen H (2017) The structure and function of the Na, K-ATPase isoforms in health and disease. Front Physiol 8(371):1–16. https://doi.org/10.3389/fphys.2017.00371
doi: 10.3389/fphys.2017.00371
Cornelius F, Kanai R, Toyoshima C (2013) A structural view on the functional importance of the sugar moiety and steroid hydroxyls of cardiotonic steroids in binding to Na, K-ATPase. J Biol Chem 288(9):6602–6616. https://doi.org/10.1074/jbc.M112.442137
doi: 10.1074/jbc.M112.442137
pubmed: 23341448
pmcid: 3585100
Crambert G, Geering K (2003) FXYD Proteins : new tissue-specific regulators of the ubiquitous Na,K-ATPase. Sci STKE, re1, 1–9. https://doi.org/10.1126/stke.2003.166.re1
Doherty JE, de Soyza N, Kane JJ, Bissett JK, Murphy ML (1978) Clinical pharmacokinetics of digitalis glycosides. Prog Cardiovasc Dis 21(2):141–158. https://doi.org/10.1016/0033-0620(78)90020-8
doi: 10.1016/0033-0620(78)90020-8
pubmed: 356122
Dolmetsch RE, Xu K, Lewis RS (1998) Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392:933–936. https://doi.org/10.1038/31960
doi: 10.1038/31960
pubmed: 9582075
Dostanic-Larson I, Lorenz JN, Van Huysse JW, Neumann JC, Moseley AE, Lingrel JB (2006) Physiological role of the α1- and α2- isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site. Am J Physiol - Regul Integr Comp Physiol 290:524–528. https://doi.org/10.1152/ajpregu.00838.2005
doi: 10.1152/ajpregu.00838.2005
Eberhart DC, Gemzik B, Halvorson MR, Parkinson A (1991) Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin. Mol Pharmacol 40:859–867
pubmed: 1944247
Eberhart D, Fitzgerald K, Parkinson A (1992) Evidence for the involvement of a distinct form of cytochrome P450 3A in the oxidation of digitoxin by rat liver microsomes. J Biochem Toxicol 7(1):53–64. https://doi.org/10.1002/jbt.2570070110
doi: 10.1002/jbt.2570070110
pubmed: 1588575
Erdogan MA, Kirazlar M, Yigitturk G, Erbas O (2022) Digoxin exhibits neuroprotective properties in a rat model of dementia. Neurochem Res 47:1290–1298. https://doi.org/10.1007/s11064-022-03528-w
doi: 10.1007/s11064-022-03528-w
pubmed: 35064518
Ferguson DW (1992) Digitalis and baroreflexes in heart failure. Trends Cardiovasc Med 2(1):21–26. https://doi.org/10.1016/1050-1738(92)90040-Y
doi: 10.1016/1050-1738(92)90040-Y
pubmed: 21239284
Furberg CD, Vittinghoff E, Davidson M, Herrington DM, Simon JA, Wenger NK, Hulley S (2002) Subgroup interactions in the heart and estrogen/progestin replacement study: lessons learned. Circulation 105:917–922. https://doi.org/10.1161/hc0802.104280
doi: 10.1161/hc0802.104280
pubmed: 11864918
Geering K (2008) Functional roles of Na, K-ATPase subunits. Curr Opin Nephrol Hypertens 17:526–532. https://doi.org/10.1097/MNH.0b013e3283036cbf
doi: 10.1097/MNH.0b013e3283036cbf
pubmed: 18695395
Gheorghiade M, Adams KF, Colucci WS (2004) Digoxin in the management of cardiovascular disorders. Circulation 109:2959–2964. https://doi.org/10.1161/01.CIR.0000132482.95686.87
doi: 10.1161/01.CIR.0000132482.95686.87
pubmed: 15210613
Haas M, Wang H, Tian J, Xie Z (2002) Src-mediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J Biol Chem 277(21):18694–18702. https://doi.org/10.1074/jbc.M111357200
doi: 10.1074/jbc.M111357200
pubmed: 11907028
Hauptman PJ, Kelly RA (1999) Digitalis. Circulation 99(9):1265–1270. https://doi.org/10.1161/01.CIR.99.9.1265
doi: 10.1161/01.CIR.99.9.1265
pubmed: 10069797
Hostrup M, Lemminger AK, Thomsen LB, Schaufuss A, Alsøe TL, Bergen GK, Bell AB, Bangsbo J, Thomassen M (2023) High-intensity training represses FXYD5 and glycosylates Na,K-ATPase in type II muscle fibres, which are linked with improved muscle K+ handling and performance. Int J Mol Sci 24(5587). https://doi.org/10.3390/ijms24065587
Kapelios CJ, Lund LH, Benson L, Dahlström U, Rosano GMC, Hauptman PJ, Savarese G (2022) Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry. Eur Heart J - Cardiovasc Pharmacother 8:756–767. https://doi.org/10.1093/ehjcvp/pvab079
doi: 10.1093/ehjcvp/pvab079
pubmed: 34921603
Katz A, Lifshitz Y, Bab-Dinitz E, Kapri-Pardes E, Goldshleger R, Tal DM, Karlish SJD (2010) Selectivity of digitalis glycosides for isoforms of human Na, K-ATPase. J Biol Chem 285(25):19582–19592. https://doi.org/10.1074/jbc.M110.119248
doi: 10.1074/jbc.M110.119248
pubmed: 20388710
pmcid: 2885237
Khalil S (1974) The uptake of digoxin and digitoxin by some antacids. J Pharm Pharmacol 26:961–967
doi: 10.1111/j.2042-7158.1974.tb09216.x
pubmed: 4156862
Kjeldsen K (2003) Myocardial Na, K-ATPase: clinical aspects. Exp Clin Cardiol 8(3):131–133
pubmed: 19641704
pmcid: 2716273
Kjeldsen K, Bundgaard H (2003) Myocardial Na, K-ATPase and digoxin therapy in human heart failure. Ann N Y Acad Sci 986:702–707. https://doi.org/10.1111/j.1749-6632.2003.tb07285.x
doi: 10.1111/j.1749-6632.2003.tb07285.x
pubmed: 12763921
Kotecha D, Bunting KV, Gill SK, Mehta S, Stanbury M, Jones JC, Haynes S, Calvert MJ, Deeks JJ, Steeds RP, Strauss VY, Rahimi K, Camm AJ, Griffith M, Lip GYH, Townend JN, Kirchhof P, Domingos P, Grant M, … Stoll V (2020). Effect of digoxin vs bisoprolol for heart rate control in atrial fibrillation on patient-reported quality of life: the RATE-AF randomized clinical trial. JAMA - J Am Med Assoc 324(24):2497–2508. https://doi.org/10.1001/jama.2020.23138
Krikler DM (1985) The foxglove, “the old woman from Shropshire” and William Withering. J Am Coll Cardiol 5(5):3A-9A. https://doi.org/10.1016/S0735-1097(85)80457-5
doi: 10.1016/S0735-1097(85)80457-5
pubmed: 3886750
Kuschinsky K, van Zwieten PA (1969) Über das Verhalten von Digoxin, Digitoxin und Digitoxigenin in isoliertem Herzgewebe und im Plasma von Meerschweinchen nach Reserpin-Vorbehandlung. Naunyn Schmiedebergs Arch Pharmakol Exp Pathol 262:463–473. https://doi.org/10.1007/BF00537843
doi: 10.1007/BF00537843
Laudisio A, Marzetti E, Pagano F, Cocchi A, Bernabei R, Zuccalà G (2009) Digoxin and cognitive performance in patients with heart failure: a cohort, pharmacoepidemiological survey. Drugs Aging 26(2):103–112. https://doi.org/10.2165/0002512-200926020-00002
doi: 10.2165/0002512-200926020-00002
pubmed: 19220067
Lee D-H, Oh SC, Giles AJ, Jung J, Gilbert MR, Park DM (2017) Cardiac glycosides suppress the maintenance of stemness and malignancy via inhibiting HIF-1α in human glioma stem cells. Oncotarget 8(25):40233–40245. https://doi.org/10.18632/oncotarget.16714
Lely AH, van Enter CHJ (1972) Non-cardiac symptoms of digitalis intoxication. Am Heart J 83(2):149–152. https://doi.org/10.1016/0002-8703(72)90132-9
doi: 10.1016/0002-8703(72)90132-9
pubmed: 4554547
Liang M, Cai T, Tian J, Qu W, Xie ZJ (2006) Functional characterization of Src-interacting Na/K-ATPase using RNA interference assay. J Biol Chem 281(28):19709–19719. https://doi.org/10.1074/jbc.M512240200
doi: 10.1074/jbc.M512240200
pubmed: 16698801
Liss M, Radke MH, Eckhard J, Neuenschwander M, Dauksaite V, von Kries J-P, Gotthardt M (2018) Drug discovery with an RBM20 dependent titin splice reporter identifies cardenolides as lead structures to improve cardiac filling. PLoS ONE 13(6):1–19. https://doi.org/10.1371/journal.pone.0198492
doi: 10.1371/journal.pone.0198492
Lorenz K, Rosner MR (2022) Harnessing RKIP to combat heart disease and cancer. Cancers 14(4). https://doi.org/10.3390/cancers14040867
Ludwig W-D, Mühlbauer B, Seifert R (2023) Arzneiverordnungs-Report 2023. https://doi.org/10.1007/978-3-662-68371-2
Lüllmann H, Ravens U (1973) The time courses of the changes in contractile force and in transmembrane potentials induced by cardiac glycosides in guinea-pig papillary muscle. Br J Pharmacol 49(3):377–390. https://doi.org/10.1111/j.1476-5381.1973.tb17248.x
doi: 10.1111/j.1476-5381.1973.tb17248.x
pubmed: 4777701
pmcid: 1776486
Mackenzie J (1911) Digitalis. Heart II(4)
Magpusao AN, Omolloh G, Johnson J, Gascón J, Peczuh MW, Fenteany G (2015) Cardiac glycoside activities link Na+/K+ ATPase ion-transport to breast cancer cell migration via correlative SAR. ACS Chem Biol 10:561–569. https://doi.org/10.1021/cb500665r
doi: 10.1021/cb500665r
pubmed: 25334087
Mann CN, Shreedarshanee SD, Kersting CT, Bleem AV, Karch CM, Holtzman DM, Gallardo G (2022) Astrocytic α2-Na+/K+ ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model. 14(632):1–25. https://doi.org/10.1126/scitranslmed.abm4107.Astrocytic
Marcus FI (1975) Digitalis pharmacokinetics and metabolism. Am J Med 58:452–459. https://doi.org/10.1016/0002-9343(75)90116-3
doi: 10.1016/0002-9343(75)90116-3
pubmed: 1092160
Marcus FI (1985) Pharmacokinetic interactions between digoxin and other drugs. J Am Coll Cardiol 5(5):82A-90A. https://doi.org/10.1016/S0735-1097(85)80466-6
doi: 10.1016/S0735-1097(85)80466-6
pubmed: 2985676
McDonagh TA, Metra M, Adamo M, Baumbach A, Böhm M, Burri H, Butler J, Čelutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599–3726. https://doi.org/10.1093/eurheartj/ehab368
doi: 10.1093/eurheartj/ehab368
pubmed: 34447992
McRitchie RJ, Vatner SF, Boettcher D, Heyndrickx GR, Patrick TA, Braunwald E (1976) Role of arterial baroreceptors in mediating cardiovascular response to exercise. Am J Physiol 230(1):85–89. https://doi.org/10.1152/ajplegacy.1976.230.1.85
doi: 10.1152/ajplegacy.1976.230.1.85
pubmed: 1251915
Merck (2022) Informationen zur Verfügbarkeit von Digimerck® Tabletten und Injektionslösung
Mijatovic T, Van Quaquebeke E, Delest B, Debeir O, Darro F, Kiss R (2007) Cardiotonic steroids on the road to anti-cancer therapy. Biochem Biophys Acta 1776:32–57. https://doi.org/10.1016/j.bbcan.2007.06.002
doi: 10.1016/j.bbcan.2007.06.002
pubmed: 17706876
Milliken J (1979) Interactions of digitalis. CMA 121:263–264
Mobasheri A, Avila J, Cózar-Castellano I, Brownleader MD, Trevan M, Francis MJO, Lamb JF, Martín-Vasallo P (2000) Na+, K+-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Biosci Rep 20(2):51–91. https://doi.org/10.1023/A:1005580332144
doi: 10.1023/A:1005580332144
pubmed: 10965965
IARC Monographs (2013) Some drugs and herbal products. In International Agency for Research on Cancer (vol 108). https://doi.org/10.5059/yukigoseikyokaishi.49.346
Murphy KT, Aughey RJ, Petersen AC, Clark SA, Goodman C, Hawley JA, Cameron-Smith D, Snow RJ, McKenna MJ (2007) Effects of endurance training status and sex differences on Na +, K+-pump mRNA expression, content and maximal activity in human skeletal muscle. Acta Physiol 189:259–269. https://doi.org/10.1111/j.1748-1716.2006.01635.x
doi: 10.1111/j.1748-1716.2006.01635.x
Neri A, Aygen M, Zukerman Z, Bahary C (1980) Subjective assessment of sexual dysfunction of patients on long-term administration of digoxin. Arch Sex Behav 9(4):343–347. https://doi.org/10.1007/BF01541359
doi: 10.1007/BF01541359
pubmed: 7416947
Ogawa H, Shinoda T, Cornelius F, Toyoshima C (2009) Crystal structure of the sodium-potassium pump (Na, K-ATPase) with bound potassium and ouabain. PNAS 106(33):13742–13747. https://doi.org/10.1073/pnas.0907054106
doi: 10.1073/pnas.0907054106
pubmed: 19666591
pmcid: 2728964
Osman MH, Farrag E, Selim M, Osman MS, Hasanine A, Selim A (2017) Cardiac glycosides use and the risk and mortality of cancer; systematic review and meta-Analysis of observational studies. PLoS ONE 12(6):1–22. https://doi.org/10.1371/journal.pone.0178611
doi: 10.1371/journal.pone.0178611
Palacios J, Marusic ET, Lopez NC, Gonzalez M, Michea L (2004) Estradiol-induced expression of Na+-K+-ATPase catalytic isoforms in rat arteries: gender differences in activity mediated by nitric oxide donors. Am J Physiol - Heart Circ Physiol 286:1793–1800. https://doi.org/10.1152/ajpheart.00990.2003
doi: 10.1152/ajpheart.00990.2003
Patocka J, Nepovimova E, Wu W, Kuca K (2020) Digoxin: pharmacology and toxicology—a review. Environ Toxicol Pharmacol 79:103400. https://doi.org/10.1016/j.etap.2020.103400
doi: 10.1016/j.etap.2020.103400
pubmed: 32464466
Petschenka G, Züst T, Hastings AP, Agrawal AA, Jander G (2023) Quantification of plant cardenolides by HPLC, measurement of Na+/K+-ATPase inhibition activity, and characterization of target enzymes. Methods Enzymol 680:275–302. https://doi.org/10.1016/bs.mie.2022.08.003
doi: 10.1016/bs.mie.2022.08.003
pubmed: 36710014
Prassas I, Diamandis EP (2008) Novel therapeutic applications of cardiac glycosides. Nat Rev Drug Discov 7:926–935. https://doi.org/10.1038/nrd2682
doi: 10.1038/nrd2682
pubmed: 18948999
Quest JA, Gillis RA (1974) Effect of digitalis on carotid sinus baroreceptor activity. Circ Res 35:247–255. https://doi.org/10.1161/01.RES.35.2.247
doi: 10.1161/01.RES.35.2.247
Rathore SS, Wang Y, Krumholz HM (2002) Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 347(18):1403–1411. https://doi.org/10.1056/nejmoa021266
doi: 10.1056/nejmoa021266
pubmed: 12409542
Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM (2003) Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA – J Am Med Assoc 289(7):871–878. https://doi.org/10.1001/jama.289.7.871
doi: 10.1001/jama.289.7.871
Regitz-Zagrosek V (2006) Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov, pp 1–14. https://doi.org/10.1038/nrd2032
Remme WJ, Swedberg K (2001) Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22:1527–1560. https://doi.org/10.1053/euhj.2001.2783
doi: 10.1053/euhj.2001.2783
pubmed: 11492984
Rifka SM, Pita JC, Vigersky RA, Wilson YA, Lynn Loriaux D (1978) Interaction of digitalis and spironolactone with human sex steroid receptors. J Clin Endocrinol Metab 46(2):338–344. https://doi.org/10.1210/jcem-46-2-338
doi: 10.1210/jcem-46-2-338
pubmed: 86546
Sayour NV, Paál ÁM, Ameri P, Meijers WC, Minotti G, Andreadou I, Lombardo A, Camilli M, Drexel H, Grove EL, Dan GA, Ivanescu A, Semb AG, Savarese G, Dobrev D, Crea F, Kaski JC, de Boer RA, Ferdinandy P, Varga ZV (2024) Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence. Eur Heart J 45:1224–1240. https://doi.org/10.1093/eurheartj/ehae105
doi: 10.1093/eurheartj/ehae105
pubmed: 38441940
pmcid: 11023004
Schimmel K, Jung M, Foinquinos A, José GS, Beaumont J, Bock K, Grote-Levi L, Xiao K, Bär C, Pfanne A, Just A, Zimmer K, Ngoy S, López B, Ravassa S, Samolovac S, Janssen-Peters H, Remke J, Scherf K, … Thum T (2020) Natural compound library screening identifies new molecules for the treatment of cardiac fibrosis and diastolic dysfunction. Circulation 141:751–767. https://doi.org/10.1161/CIRCULATIONAHA.119.042559
Schmid E, Neef S, Berlin C, Tomasovic A, Kahlert K, Nordbeck P, Deiss K, Denzinger S, Herrmann S, Wettwer E, Weidendorfer M, Becker D, Schäfer F, Wagner N, Ergün S, Schmitt JP, Katus HA, Weidemann F, Ravens U, … Lorenz K (2015) Cardiac RKIP induces a beneficial β-adrenoceptor-dependent positive inotropy. Nat Med 21(11):1298–1306. https://doi.org/10.1038/nm.3972
Schönfeld W, Weiland J, Lindig C, Masnyk M, Kabat MM, Kurek A, Wicha J, Repke KRH (1985) The lead structure in cardiac glycosides is 5 β,14 β-androstane-3 β,14-diol. Naunyn-Schmiedeberg’s Arch Pharmacol 329(4):414–426. https://doi.org/10.1007/BF00496377
doi: 10.1007/BF00496377
Schwinger RHG, Bundgaard H, Müller-Ehmsen J, Kjeldsen K (2003) The Na, K-ATPase in the failing human heart. Cardiovasc Res 57:913–920. https://doi.org/10.1016/S0008-6363(02)00767-8
doi: 10.1016/S0008-6363(02)00767-8
pubmed: 12650869
Segall L, Javaid ZZ, Carl SL, Lane LK, Blostein R (2003) Structural basis for α1 versus α2 isoform-distinct behavior of the Na, K-ATPase. J Biol Chem 278(11):9027–9034. https://doi.org/10.1074/jbc.M211636200
doi: 10.1074/jbc.M211636200
pubmed: 12529322
Shattock MJ, Ottolia M, Bers DM, Blaustein MP, Boguslavskyi A, Bossuyt J, Bridge JHB, Chen-Izu Y, Clancy CE, Edwards A, Goldhaber J, Kaplan J, Lingrel JB, Pavlovic D, Philipson K, Sipido KR, Xie Z-J (2015) Na+/Ca2+ exchange and Na+/K+-ATPase in the heart. J Physiol 593(6):1361–1382. https://doi.org/10.1113/jphysiol.2014.282319
doi: 10.1113/jphysiol.2014.282319
pubmed: 25772291
pmcid: 4376416
Slingerland M, Cerella C, Guchelaar HJ, Diederich M, Gelderblom H (2013) Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials. Invest New Drugs 31:1087–1094. https://doi.org/10.1007/s10637-013-9984-1
doi: 10.1007/s10637-013-9984-1
pubmed: 23748872
Smith TW (1985) Pharmacokinetics, bioavailability and serum levels of cardiac glycosides. J Am Coll Cardiol 5(5):43A-50A. https://doi.org/10.1016/S0735-1097(85)80462-9
doi: 10.1016/S0735-1097(85)80462-9
pubmed: 3921586
Steiness E (1978) Suppression of renal excretion of digoxin in hypokalemic patients. Clin Pharmacol Ther 23(5):511–514. https://doi.org/10.1002/cpt1978235511
doi: 10.1002/cpt1978235511
pubmed: 639424
Suhail M (2010) Na+, K+-ATPase: Ubiquitous multifunctional transmembrane protein and its relevance to various pathophysiological conditions. J Clin Medi Res 2(1):1–17. https://doi.org/10.4021/jocmr2010.02.263w
doi: 10.4021/jocmr2010.02.263w
Thames MD (1979) Acetylstrophanthidin-induced reflex inhibition of canine renal sympathetic nerve activity mediated by cardiac receptors with vagal afferents. Circ Res 44:8–15. https://doi.org/10.1161/01.RES.44.1.8
doi: 10.1161/01.RES.44.1.8
pubmed: 758235
The Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336(8):525–533. https://doi.org/10.1056/nejm199702203360801
doi: 10.1056/nejm199702203360801
Tokugawa M, Inoue Y, Aoki H, Miyajima C, Ishiuchi K, Tsurumi K, Kujirai C, Morishita D, Matsuno M, Mizukami H, Ri M, Iida S, Makino T, Aoyama M, Hayashi H (2024) Involvement of cardiac glycosides targeting Na/K-ATPase in their inhibitory effects on c-Myc expression via its transcription, translation and proteasomal degradation. J Biochem 175(3):253–263. https://doi.org/10.1093/jb/mvad085
doi: 10.1093/jb/mvad085
pubmed: 37948630
Van Veldhuisen DJ, Bauersachs J (2023) Digitalis in heart failure: declining use and ongoing outcome trials. Eur Heart J 44(22):1976–1978. https://doi.org/10.1093/eurheartj/ehad185
doi: 10.1093/eurheartj/ehad185
pubmed: 37029703
Watanabe AM (1985) Digitalis and the autonomic nervous system. J Am Coll Cardiol 5:35A-42A. https://doi.org/10.1016/S0735-1097(85)80461-7
doi: 10.1016/S0735-1097(85)80461-7
pubmed: 3886751
Yatime L, Laursen M, Morth JP, Esmann M, Nissen P, Fedosova NU (2011) Structural insights into the high affinity binding of cardiotonic steroids to the Na+, K+-ATPase. J Struct Biol 174:296–306. https://doi.org/10.1016/j.jsb.2010.12.004
doi: 10.1016/j.jsb.2010.12.004
pubmed: 21182963
Zhang S, Malmersjö S, Li J, Ando H, Aizman O, Uhlén P, Mikoshiba K, Aperia A (2006) Distinct role of the N-terminal tail of the Na, K-ATPase catalytic subunit as a signal transducer. J Biol Chem 281(31):21954–21962. https://doi.org/10.1074/jbc.M601578200
doi: 10.1074/jbc.M601578200
pubmed: 16723354